Decreased TUSC3 Promotes Pancreatic Cancer Proliferation, Invasion and Metastasis
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Decreased TUSC3 Promotes Pancreatic Cancer Proliferation, Invasion and Metastasis
Authors
Keywords
Pancreatic cancer, Transcription factors, Metastasis, Gene expression, Mouse models, Ovarian cancer, Protein expression, Tumor suppressor genes
Journal
PLoS One
Volume 11, Issue 2, Pages e0149028
Publisher
Public Library of Science (PLoS)
Online
2016-02-13
DOI
10.1371/journal.pone.0149028
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Tumor suppressor candidate 3 (TUSC3) prevents the epithelial-to-mesenchymal transition and inhibits tumor growth by modulating the endoplasmic reticulum stress response in ovarian cancer cells
- (2015) Kateřina Kratochvílová et al. INTERNATIONAL JOURNAL OF CANCER
- Prognostic Impact of CA 19-9 on Outcome after Neoadjuvant Chemoradiation in Patients with Locally Advanced Pancreatic Cancer
- (2014) Stephanie E. Combs et al. ANNALS OF SURGICAL ONCOLOGY
- Cooperativity of Oncogenic K-Ras and Downregulated p16/INK4A in Human Pancreatic Tumorigenesis
- (2014) Zhe Chang et al. PLoS One
- TUSC3 Loss Alters the ER Stress Response and Accelerates Prostate Cancer Growth in vivo
- (2014) Peter Horak et al. Scientific Reports
- Validation of C-reactive protein levels as a prognostic indicator for survival in a large cohort of pancreatic cancer patients
- (2013) J Szkandera et al. BRITISH JOURNAL OF CANCER
- Adjuvant Chemotherapy With Gemcitabine and Long-term Outcomes Among Patients With Resected Pancreatic Cancer
- (2013) Helmut Oettle et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
- (2013) Daniel D. Von Hoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Multicentre phase II trial of trastuzumab and capecitabine in patients with HER2 overexpressing metastatic pancreatic cancer
- (2012) J Harder et al. BRITISH JOURNAL OF CANCER
- Cancer statistics, 2012
- (2012) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Methylation status ofTUSC3is a prognostic factor in ovarian cancer
- (2012) Dietmar Pils et al. CANCER
- Genome profiling of pancreatic adenocarcinoma
- (2011) David J. Birnbaum et al. GENES CHROMOSOMES & CANCER
- Oligosaccharyltransferase: the central enzyme of N-linked protein glycosylation
- (2011) Elisabeth Mohorko et al. JOURNAL OF INHERITED METABOLIC DISEASE
- FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
- (2011) Thierry Conroy et al. NEW ENGLAND JOURNAL OF MEDICINE
- Preoperative Neutrophil-to-Lymphocyte Ratio (NLR) is Associated with Reduced Disease-free Survival Following Curative Resection of Pancreatic Adenocarcinoma
- (2011) G. Garcea et al. WORLD JOURNAL OF SURGERY
- K-ras mutational status predicts poor prognosis in unresectable pancreatic cancer
- (2010) H. Chen et al. EJSO
- Epidemiology of pancreatic cancer: an overview
- (2009) Sara Raimondi et al. Nature Reviews Gastroenterology & Hepatology
- Mammalian MagT1 and TUSC3 are required for cellular magnesium uptake and vertebrate embryonic development
- (2009) H. Zhou et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- High-resolution array CGH clarifies events occurring on 8p in carcinogenesis
- (2008) Susanna L Cooke et al. BMC CANCER
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started